Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes

Fig. 1

Box plot depicting differences in pHDL activity at baseline and after 12 months of IMT. As illustrated, there were significant differences at baseline between subjects with T2D and controls. After 12 months of IMT, a per-protocol analysis, which omitted the non-adherent subject, indicated that pHDL activity significantly decreased. p-values: Wilcoxon rank sum test for intergroup differences, whereas within-group differences were analyzed via the Wilcoxon signed rank test. DM, type II diabetics; pHDL, pro-inflammatory high-density lipoprotein activity

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X